FDA Advisory Panel Backs Adding Several Unproven Peptides to Approved List

An FDA advisory panel has recommended adding a number of peptides — short chains of amino acids — to the agency's bulk compounding list, despite limited clinical evidence supporting their safety or efficacy. Some panel members were noted to have a vested interest in the peptide industry, raising conflict-of-interest concerns. Among the substances endorsed was a combination known as the 'Wolverine stack,' which has been widely promoted by podcaster Joe Rogan and other social media influencers. The recommendation moves these compounds closer to broader legal availability through compounding pharmacies. The FDA will now consider the panel's advice before making a final regulatory decision.